November 8, 2024

In a study published in the BMJ on March 27, 2024, researchers at the National Agency for Medicines and Health Products Safety in France announced findings that indicate use of certain hormone drugs may be putting millions of women worldwide at a heightened “risk of rare, usually benign brain [tumors].”